Intelligent Bio Solutions (INBS) Short Interest Ratio & Short Volume

Short interest is the volume of Intelligent Bio Solutions shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 420,600 shares of INBS short. 9.80% of Intelligent Bio Solutions' shares are currently sold short. Learn More on Intelligent Bio Solutions' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.80% of Intelligent Bio Solutions' floating shares are currently sold short.

Intelligent Bio Solutions saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 420,600 shares, an increase of 13.9% from the previous total of 369,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Intelligent Bio Solutions currently has issued a total of 4,390,000 shares. Some of Intelligent Bio Solutions' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intelligent Bio Solutions currently has a public float of 4,290,000 shares.

9.80% of Intelligent Bio Solutions' shares are currently sold short. Here is how the short interest of companies compare to Intelligent Bio Solutions: NeuroOne Medical Technologies Co. (0.46%), BioSig Technologies, Inc. (1.98%), Precision Optics Co., Inc. (0.12%), DarioHealth Corp. (5.40%), Spectral AI, Inc. (11.59%), Beyond Air, Inc. (3.07%), IRIDEX Co. (2.49%), Femasys Inc. (2.56%), ReWalk Robotics Ltd. (1.94%), Neuronetics, Inc. (2.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling INBS is an investing strategy that aims to generate trading profit from Intelligent Bio Solutions as its price is falling. INBS shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Intelligent Bio Solutions occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBS, twice per month. The most recent reporting period available is October, 31 2024.